Doximity (DOCS) Stock & Financials
Data as of (185 days ago)|Source: SEC EDGAR
Doximity (DOCS) is a health care technology company. The company reports annual revenue of $570M and net income of $223M. Its profit margin is 39.1%.
What to check next
For informational purposes only. Not investment advice. Data may be delayed or inaccurate; verify independently. The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results. Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing.
Doximity Key Financials
Data from SEC EDGAR filings. TTM = Trailing Twelve Months.
Doximity Financial Health ScoreFY2026
Good overall health with some areas for improvement
-7 pts YoYThis Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Data Highlights
- Profit margin: 39.1% of revenue retained as profit
Data sourced from SEC EDGAR filings. Not investment advice.
5-Year Revenue & Net Income Trend
Chart shows fiscal year data from SEC EDGAR filings. Hover over data points for details.
About Doximity
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
- Industry
- Health Care Technology
Valuation
Valuation Data UnavailablePrice-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
Profitability
Above-Average Marginsvs 4.7% sector median / 4.6% avg
Keeps 39 cents of every dollar in revenue as profit. Higher than 99% in Health Care.
Profit margin 287% above industry average.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
Financial Health
Balance Sheet Data LimitedInsufficient data to assess financial health.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend
Dividend Data UnavailableDividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
Doximity 8-Year Revenue, Profit & Cash Flow History
Revenue has grown at a 22.3% CAGR over the past 7 years.
Annual Financials
FY2026 - FY2019| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $475.4M(-26.3%) | $644.9M(+13.1%) | $570.4M(+20.0%) | $475.4M(+308.5%) | $116.4M(-66.1%) | $343.5M(+66.0%) | $206.9M(+77.8%) | $116.4M |
| Net Income | $147.6M(-24.7%) | $196.1M(-12.2%) | $223.2M(+51.2%) | $147.6M(+396.3%) | $29.7M(-80.8%) | $154.8M(+208.3%) | $50.2M(+68.8%) | $29.7M |
| Total Assets | - | $1.3B | $1.1B | $1.1B | $991.4M | $251.7M | - | - |
| Total Debt | - | - | - | - | - | - | - | - |
| Total Equity | - | $1.1B | $901.4M | $966.1M | $1.1M | $66.7M | $1.1M | $-32,935,000 |
| Profit Margin | 31.0% | 30.4% | 39.1% | 31.0% | 25.6% | 45.1% | 24.3% | 25.6% |
| ROE | - | 18.1% | 24.8% | 15.3% | 2617.7% | 231.9% | 4419.9% | - |
| ROA | - | 15.5% | 20.7% | 13.0% | 3.0% | 61.5% | - | - |
Quarterly Financials
Last 8 quarters| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $432.1M | $263.5M | $126.7M | $168.5M | $145.9M | - | $136.8M | $126.7M |
| Net Income | $160.7M | $85.5M | $41.4M | $62.1M | $53.3M | - | $44.2M | $41.4M |
| Total Assets | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | $1.3B | $1.1B | $1.1B |
Insider Trading
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
Doximity Free Cash Flow & Dividend Coverage
Cash Flow History
FY2019 - FY2026| Metric | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $26.2M | $83.0M | $126.6M | $26.2M | $184.1M | $273.3M | $326.5M | $184.1M |
| CapEx | -$285,000 | -$245,000 | -$1.9M | -$285,000 | -$147,000 | - | - | -$147,000 |
| Free Cash Flow | $25.9M | $82.7M | $124.7M | $25.9M | $183.9M | $273.3M | $326.5M | $183.9M |
| FCF Margin | 22.3% | 40.0% | 36.3% | 22.3% | 38.7% | 47.9% | 50.6% | 38.7% |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
Doximity Risk Factors
Company-disclosed SEC risk factors
Risk factors are disclosed by the company in its SEC Form 10-K, Item 1A. Billiver does not classify or summarize company-specific legal, operational, financial, or market risks here.
Sector context: Health Care. This is not a Billiver risk assessment for DOCS.
Source note: the SEC Form 10-K includes Item 1A, "Risk Factors." The full risk-factor text should be read from the company’s own SEC filing.
Doximity FAQ
What is Doximity's annual revenue?
Doximity (DOCS) reported $570 million in trailing twelve-month (TTM) revenue. This financial data is compiled from SEC EDGAR 10-K filings.
Is Doximity profitable?
Yes, Doximity is profitable with a 39.1% net profit margin and $223 million in net income (TTM). All figures from SEC EDGAR 10-K filings.
Does Doximity pay dividends?
No, Doximity (DOCS) does not currently pay dividends to shareholders.
What is Doximity's financial health score?
Doximity has a financial health score of 73/100 (Grade: B), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
How many years of Doximity financial data are available?
8 years of financial data are available for Doximity from FY2019 to FY2026. All figures are compiled from SEC EDGAR 10-K filings.